Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Head to head comparison of two commercial fecal calprotectin kits as predictor of Mayo endoscopic sub-score and mucosal TNF expression in ulcerative colitis

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Antibiotic treatment adequacy and death among patients with Pseudomonas aeruginosa airway infection

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Incidence, prevalence and risk factors for hepatitis C in Danish prisons

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Plasma calprotectin is superior to serum calprotectin as a biomarker of intestinal inflammation in ulcerative Colitis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Coping Among Parents of Teens With Inflammatory Bowel Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Serum Calprotectin in Adolescents with Inflammatory Bowel Disease - A Pilot Investigation

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. A Personalized eHealth Transition Concept for Adolescents With Inflammatory Bowel Disease: Design of Intervention

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Challenges and obstacles in the transition process through the eyes of the gastroenterologist

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Rasmus Goll
  • Richard Heitmann
  • Øystein Kittel Moe
  • Katrine Carlsen
  • Jon Florholmen
View graph of relations

BACKGROUND: Fecal calprotectin is widely used to monitor disease activity in patients with inflammatory bowel disease. Multiple commercial kits exist, however, since the analyses are not standardized, these kits cannot be used interchangeably. We aimed to perform a technical evaluation of two kits (Calpro from Calprolab, Norway and Calprest from Eurospital, Italy) and perform a tuning for detection of clinically relevant disease states in ulcerative colitis.

MATERIALS AND METHODS: For tuning against different clinical states a total of 116 patients with ulcerative colitis were recruited (67 of which were part of an earlier publication). For the technical evaluation an additional series of 80 random samples from the hospital lab were included. Technical evaluation was done by correlation and limits of agreement analysis; cut-off levels were explored by ROC analysis against clinically relevant actual states.

RESULTS: The technical evaluation revealed good correlation between assays, however a non-linear difference was found: At values below 200 mg/kg, no significant bias was found; in the interval 200-1000 mg/kg the Calprest assay measured on average 30% lower than Calpro; and at higher values Calprest measured 60% higher values than Calpro. Both assays predicted Mayo endoscopic score (MES) 0 (cutoff 28: sensitivity 0.38; specificity 0.82 for Calprest; cutoff 28: sensitivity 0.50; specificity 0.77 for Calpro), and MES 2-3 (cutoff 148: sensitivity 0.72; specificity 0.80 for Calprest; cutoff 208: sensitivity 0.64; specificity 0.80 for Calpro), but did not predict normalization of mucosal TNF transcript per se. A combination of calprotectin and MES predicted mucosal TNF transcript values reasonably well (Calpro: sensitivity 0.85, specificity 0.58; Calprest: sensitivity 0.85, specificity 0.61).

CONCLUSION: The Calpro and Calprest assays correlated well, but subtle differences were found, underlining the need for kit-specific cut-off values. Both kits were most precise in predicting active inflammation (MES 2-3), but less so for prediction of mucosal healing (MES 0) and normalization of mucosal TNF gene expression.

Original languageEnglish
Article numbere0224895
JournalPLoS One
Volume14
Issue number12
Number of pages12
ISSN1932-6203
DOIs
Publication statusPublished - 2 Dec 2019

ID: 58515158